The invention encompasses compounds of Formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV. ##STR00001##

 
Web www.patentalert.com

< Method for selective inactivation of viral replication

> Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

~ 00478